Phase I and translational study of capecitabine, cisplatin, and irinotecan in patients with solid tumors.

被引：0
|
作者：
Verschraegen, CF [1 ]
Lee, FC [1 ]
Rabinowitz, I [1 ]
Mangalik, A [1 ]
Jennings, C [1 ]
Maestas, A [1 ]
Shen, Z [1 ]
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2114
引用
收藏
页码：155S / 155S
页数：1
相关论文
共 50 条
  • [41] Phase I and pharmacokinetic study of docetaxel and irinotecan in patients with advanced solid tumors
    Couteau, C
    Risse, ML
    Ducreux, M
    Lefresne-Soulas, F
    Riva, A
    Lebecq, A
    Ruffié, P
    Rougier, P
    Lokiec, F
    Bruno, R
    Armand, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3545 - 3552
  • [42] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
  • [43] A phase I study of metformin and chemotherapy in solid tumors.
    Kritharis, Athena
    Caplain, Jennifer
    Rajagopal, Shrikar
    Grimm, Elizabeth
    Tsichlis, Philip N.
    Martell, Robert
    Saif, Waslf M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Phase I and pharmacokinetic study of farletuzumab in solid tumors.
    Sasaki, Yasutsuna
    Miwa, Keisuke
    Yamashita, Keishi
    Fujiwara, Keiichi
    Katsumata, Noriyuki
    Fujiwara, Yasuhiro
    Namiki, Masayuki
    Koyanagi, Nozomu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] A phase I and pharmacokinetic (PK) study of high dose selenomethionine (SLM) in combination with irinotecan (IRI) in patients with advanced solid tumors.
    Rustum, Y
    Pendyala, L
    Creaven, PJ
    Smith, P
    Azrak, R
    Cao, S
    Durrani, F
    Lawrence, DD
    Badmaev, V
    Diane, NC
    Fakih, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 154S - 154S
  • [46] Irinotecan and gemcitabine in patients with solid tumors: Phase I trial
    Lima, CMSR
    Leong, SS
    Sherman, CA
    Perkel, JA
    Putman, T
    Safa, AR
    Green, MR
    ONCOLOGY-NEW YORK, 2002, 16 (05): : 19 - 24
  • [47] Phase I Study of Weekly Cisplatin, Bolus Fluorouracil and Escalating Doses of Irinotecan in Advanced Solid Tumors
    Ku, Geoffrey Y.
    O'Reilly, Eileen M.
    Saltz, Leonard B.
    Schrag, Deborah
    Maki, Robert G.
    Kelsen, David P.
    Ilson, David H.
    CANCER INVESTIGATION, 2009, 27 (04) : 402 - 406
  • [48] Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors
    Souid, AK
    Dubowy, RL
    Blaney, SM
    Hershon, L
    Sullivan, J
    McLeod, WD
    Bernstein, ML
    CLINICAL CANCER RESEARCH, 2003, 9 (02) : 703 - 710
  • [49] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [50] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345